← All trials
NCT07107659
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 4, 2026
- Primary completion
- May 31, 2030
- Completion date
- May 31, 2030
- First posted
- Aug 6, 2025
- Last posted
- Nov 20, 2025
- Enrollment
- 61
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Rockefeller UniversityLead sponsor
- University of Texas, GalvestonCollaborator
- Rockefeller UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.